Search

everythinglearnresearchcommunity

for

Search:↓

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Understanding breast cancer requires considering both medical advancements and social influences.

Some breast cancer chemotherapy can cause permanent hair loss.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.